Company Filing History:
Years Active: 2022-2023
Title: Fude Huang: Innovator in Alzheimer's Disease Research
Introduction
Fude Huang is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of Alzheimer's disease research. With a focus on innovative therapeutic methods, he has been instrumental in developing strategies to combat this debilitating condition. His work has led to the filing of 2 patents that aim to improve the understanding and treatment of Alzheimer's disease.
Latest Patents
Huang's latest patents include groundbreaking methods for treating Alzheimer's disease. One patent details the application of the PI4KIIIA protein and related membrane protein complex in treating Alzheimer's disease. This method involves using a genetic approach to down-regulate specific proteins, such as RBO/EFR3/EFR3A/EFR3B and TTC7, which interact with the PI4KIIIα enzyme. The research demonstrates that inhibiting PI4KIIIα protein kinase activity can reduce the accumulation of Aβ within neurons, thereby improving learning and memory abilities in Alzheimer's model mice. Another patent focuses on screening drugs for treating Alzheimer's disease by promoting Aβ secretion from nerve cells, which is crucial for identifying effective therapeutic targets.
Career Highlights
Fude Huang is currently associated with Jiangsu Nuo-beta Pharmaceutical Technology Co. Ltd., where he continues to advance his research in neurodegenerative diseases. His innovative approaches have garnered attention in the scientific community, contributing to the development of potential treatments for Alzheimer's disease.
Collaborations
Huang collaborates with notable colleagues, including Xiao Xun Zhang and Wenan Wang, who share his commitment to advancing research in the field of Alzheimer's disease. Their combined expertise enhances the potential for impactful discoveries.
Conclusion
Fude Huang's work exemplifies the innovative spirit necessary to tackle complex health challenges such as Alzheimer's disease. His patents and research efforts are paving the way for new therapeutic strategies that could significantly improve the lives of those affected by this condition.